United States Circulating Biomarker Market Report 2017

United States Circulating Biomarker Market Report 2017

1 Circulating Biomarker Overview

1.1 Product Overview and Scope of Circulating Biomarker

1.2 Classification of Circulating Biomarker by Product Category

1.2.1 United States Circulating Biomarker Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Circulating Biomarker Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Circulating DNA

1.2.4 Circulating Tumor Cells

1.2.5 Other

1.3 United States Circulating Biomarker Market by Application/End Users

1.3.1 United States Circulating Biomarker Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Medical Research Center

1.3.4 Others

1.4 United States Circulating Biomarker Market by Region

1.4.1 United States Circulating Biomarker Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Circulating Biomarker Status and Prospect (2012-2022)

1.4.3 Southwest Circulating Biomarker Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Circulating Biomarker Status and Prospect (2012-2022)

1.4.5 New England Circulating Biomarker Status and Prospect (2012-2022)

1.4.6 The South Circulating Biomarker Status and Prospect (2012-2022)

1.4.7 The Midwest Circulating Biomarker Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Circulating Biomarker (2012-2022)

1.5.1 United States Circulating Biomarker Sales and Growth Rate (2012-2022)

1.5.2 United States Circulating Biomarker Revenue and Growth Rate (2012-2022)

2 United States Circulating Biomarker Market Competition by Players/Suppliers

2.1 United States Circulating Biomarker Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Circulating Biomarker Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Circulating Biomarker Average Price by Players/Suppliers (2012-2017)

2.4 United States Circulating Biomarker Market Competitive Situation and Trends

2.4.1 United States Circulating Biomarker Market Concentration Rate

2.4.2 United States Circulating Biomarker Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Circulating Biomarker Manufacturing Base Distribution, Sales Area, Product Type

3 United States Circulating Biomarker Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Circulating Biomarker Sales and Market Share by Region (2012-2017)

3.2 United States Circulating Biomarker Revenue and Market Share by Region (2012-2017)

3.3 United States Circulating Biomarker Price by Region (2012-2017)

4 United States Circulating Biomarker Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Circulating Biomarker Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Circulating Biomarker Revenue and Market Share by Type (2012-2017)

4.3 United States Circulating Biomarker Price by Type (2012-2017)

4.4 United States Circulating Biomarker Sales Growth Rate by Type (2012-2017)

5 United States Circulating Biomarker Sales (Volume) by Application (2012-2017)

5.1 United States Circulating Biomarker Sales and Market Share by Application (2012-2017)

5.2 United States Circulating Biomarker Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Circulating Biomarker Players/Suppliers Profiles and Sales Data

6.1 Abbott Laboratories

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Circulating Biomarker Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Abbott Laboratories Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Becton, Dickinson and Company

6.2.2 Circulating Biomarker Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Becton, Dickinson and Company Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 GE Healthcare

6.3.2 Circulating Biomarker Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 GE Healthcare Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Epigenomics AG

6.4.2 Circulating Biomarker Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Epigenomics AG Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Agilent Technologies

6.5.2 Circulating Biomarker Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Agilent Technologies Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Biocept

6.6.2 Circulating Biomarker Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Biocept Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Affymetrix

6.7.2 Circulating Biomarker Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Affymetrix Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Fluxion Biosciences

6.8.2 Circulating Biomarker Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Fluxion Biosciences Circulating Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

7 Circulating Biomarker Manufacturing Cost Analysis

7.1 Circulating Biomarker Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Circulating Biomarker

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Circulating Biomarker Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Circulating Biomarker Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Circulating Biomarker Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Circulating Biomarker Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Circulating Biomarker Sales Volume Forecast by Type (2017-2022)

11.3 United States Circulating Biomarker Sales Volume Forecast by Application (2017-2022)

11.4 United States Circulating Biomarker Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Circulating Biomarker

Figure United States Circulating Biomarker Market Size (K Units) by Type (2012-2022)

Figure United States Circulating Biomarker Sales Volume Market Share by Type (Product Category) in 2016

Figure Circulating DNA Product Picture

Figure Circulating Tumor Cells Product Picture

Figure Other Product Picture

Figure United States Circulating Biomarker Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Circulating Biomarker by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Medical Research Center Examples

Table Key Downstream Customer in Medical Research Center

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Circulating Biomarker Market Size (Million USD) by Region (2012-2022)

Figure The West Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Circulating Biomarker Sales (K Units) and Growth Rate (2012-2022)

Figure United States Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Circulating Biomarker Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Circulating Biomarker Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Circulating Biomarker Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Circulating Biomarker Sales Share by Players/Suppliers

Figure 2017 United States Circulating Biomarker Sales Share by Players/Suppliers

Figure United States Circulating Biomarker Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Circulating Biomarker Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Circulating Biomarker Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Circulating Biomarker Revenue Share by Players/Suppliers

Figure 2017 United States Circulating Biomarker Revenue Share by Players/Suppliers

Table United States Market Circulating Biomarker Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Circulating Biomarker Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Circulating Biomarker Market Share of Top 3 Players/Suppliers

Figure United States Circulating Biomarker Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Circulating Biomarker Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Circulating Biomarker Product Category

Table United States Circulating Biomarker Sales (K Units) by Region (2012-2017)

Table United States Circulating Biomarker Sales Share by Region (2012-2017)

Figure United States Circulating Biomarker Sales Share by Region (2012-2017)

Figure United States Circulating Biomarker Sales Market Share by Region in 2016

Table United States Circulating Biomarker Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Circulating Biomarker Revenue Share by Region (2012-2017)

Figure United States Circulating Biomarker Revenue Market Share by Region (2012-2017)

Figure United States Circulating Biomarker Revenue Market Share by Region in 2016

Table United States Circulating Biomarker Price (USD/Unit) by Region (2012-2017)

Table United States Circulating Biomarker Sales (K Units) by Type (2012-2017)

Table United States Circulating Biomarker Sales Share by Type (2012-2017)

Figure United States Circulating Biomarker Sales Share by Type (2012-2017)

Figure United States Circulating Biomarker Sales Market Share by Type in 2016

Table United States Circulating Biomarker Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Circulating Biomarker Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Circulating Biomarker by Type (2012-2017)

Figure Revenue Market Share of Circulating Biomarker by Type in 2016

Table United States Circulating Biomarker Price (USD/Unit) by Types (2012-2017)

Figure United States Circulating Biomarker Sales Growth Rate by Type (2012-2017)

Table United States Circulating Biomarker Sales (K Units) by Application (2012-2017)

Table United States Circulating Biomarker Sales Market Share by Application (2012-2017)

Figure United States Circulating Biomarker Sales Market Share by Application (2012-2017)

Figure United States Circulating Biomarker Sales Market Share by Application in 2016

Table United States Circulating Biomarker Sales Growth Rate by Application (2012-2017)

Figure United States Circulating Biomarker Sales Growth Rate by Application (2012-2017)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Abbott Laboratories Circulating Biomarker Sales Growth Rate (2012-2017)

Figure Abbott Laboratories Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure Abbott Laboratories Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table Becton, Dickinson and Company Basic Information List

Table Becton, Dickinson and Company Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Becton, Dickinson and Company Circulating Biomarker Sales Growth Rate (2012-2017)

Figure Becton, Dickinson and Company Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure Becton, Dickinson and Company Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table GE Healthcare Basic Information List

Table GE Healthcare Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure GE Healthcare Circulating Biomarker Sales Growth Rate (2012-2017)

Figure GE Healthcare Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure GE Healthcare Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table Epigenomics AG Basic Information List

Table Epigenomics AG Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Epigenomics AG Circulating Biomarker Sales Growth Rate (2012-2017)

Figure Epigenomics AG Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure Epigenomics AG Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table Agilent Technologies Basic Information List

Table Agilent Technologies Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Agilent Technologies Circulating Biomarker Sales Growth Rate (2012-2017)

Figure Agilent Technologies Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure Agilent Technologies Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table Biocept Basic Information List

Table Biocept Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Biocept Circulating Biomarker Sales Growth Rate (2012-2017)

Figure Biocept Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure Biocept Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table Affymetrix Basic Information List

Table Affymetrix Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Affymetrix Circulating Biomarker Sales Growth Rate (2012-2017)

Figure Affymetrix Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure Affymetrix Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table Fluxion Biosciences Basic Information List

Table Fluxion Biosciences Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Fluxion Biosciences Circulating Biomarker Sales Growth Rate (2012-2017)

Figure Fluxion Biosciences Circulating Biomarker Sales Market Share in United States (2012-2017)

Figure Fluxion Biosciences Circulating Biomarker Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Circulating Biomarker

Figure Manufacturing Process Analysis of Circulating Biomarker

Figure Circulating Biomarker Industrial Chain Analysis

Table Raw Materials Sources of Circulating Biomarker Major Players/Suppliers in 2016

Table Major Buyers of Circulating Biomarker

Table Distributors/Traders List

Figure United States Circulating Biomarker Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Circulating Biomarker Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Circulating Biomarker Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Circulating Biomarker Sales Volume (K Units) Forecast by Type in 2022

Table United States Circulating Biomarker Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Circulating Biomarker Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Circulating Biomarker Sales Volume (K Units) Forecast by Application in 2022

Table United States Circulating Biomarker Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Circulating Biomarker Sales Volume Share Forecast by Region (2017-2022)

Figure United States Circulating Biomarker Sales Volume Share Forecast by Region (2017-2022)

Figure United States Circulating Biomarker Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources